Oral pre-exposure prophylaxis (PrEP) can reduce HIV incidence among at-risk persons.
However, for PrEP to have an impact in decreasing HIV incidence, clinicians will need to be …

Background In 2010, the iPrEx trial demonstrated that oral antiretroviral pre-exposure
prophylaxis (PrEP) reduced the risk of HIV acquisition among high-risk men who have sex with …

Men who have sex with men (MSM) have the highest incidence of HIV infection in the United
States. One of the contributing factors to HIV spread among this group is the use of crystal …

Limited data exist regarding attitudes and acceptability of topical and oral HIV pre-exposure
prophylaxis (PrEP) among US black women. This investigation explored interest in HIV …

Background Antiretroviral treatment for HIV-infection before immunologic decline (early ART)
and pre-exposure chemoprophylaxis (PrEP) can prevent HIV transmission, but routine …

Pre-exposure prophylaxis (PrEP) is efficacious for HIV prevention when taken consistently;
however, barriers to PrEP use are poorly understood among individuals who could benefit …

HIV-positive inmates often have histories of substance use, mental illness, and homelessness.
Access to supportive services is important for members of this population upon their …

Men who have sex with men (MSM) remain at great risk of HIV in the United States, representing
65 % of incident HIV infections. One factor contributing to the high rate of HIV infection …

Prior to release from the Rhode Island state prison, women at the highest risk for reincarceration
and HIV infection are assigned to the Women's HIV/Prison Prevention Program (WHPPP…

The use of recreational drugs while having sex is associated with increased HIV incidence
among men who have sex with men (MSM). Taking a daily antiretroviral pill, or pre-exposure …